$CPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST PHARMACEUTICALS, INC.. Get notifications about new insider transactions in CATALYST PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 0.90 | 25,000 | 22,500 | 95,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 0.90 | 55,000 | 49,500 | 70,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | H | 1.37 | 291,844 | 399,826 | 15,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | A | 0.90 | 58,334 | 52,501 | 190,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | A | 0.90 | 58,333 | 52,500 | 131,666 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | A | 0.90 | 58,333 | 52,500 | 73,333 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | H | 3.60 | 100,000 | 360,000 | 15,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.90 | 50,000 | 45,000 | 894,608 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.90 | 50,000 | 45,000 | 844,608 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.90 | 50,000 | 45,000 | 794,608 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 0.90 | 30,000 | 27,000 | 774,608 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 0.90 | 30,000 | 27,000 | 105,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 0.90 | 30,000 | 27,000 | 75,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 0.90 | 30,000 | 27,000 | 45,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | H | 0.00 | 50,000 | 0 | 15,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.90 | 30,000 | 27,000 | 45,000 | |
Oct 02 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | J | 2.98 | 145,922 | 434,848 | 452,764 | |
Oct 02 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | J | 1.37 | 291,842 | 399,824 | 452,764 | |
May 27 2009 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 2.06 | 100 | 206 | 305,100 | 305 K to 305.1 K (+0.03 %) |
Mar 09 2009 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | P | 1.55 | 3,000 | 4,650 | 185,402 | 182.4 K to 185.4 K (+1.64 %) |
Mar 06 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 1.55 | 1,400 | 2,170 | 11,993 | 10.6 K to 12 K (+13.22 %) |
Mar 06 2009 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.55 | 5,000 | 7,750 | 3,091,071 | 3.1 M to 3.1 M (+0.16 %) |
Mar 06 2009 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | V.P. of Regulatory ... | Buy | P | 1.55 | 3,000 | 4,650 | 4,794 | 1.8 K to 4.8 K (+167.22 %) |
Feb 24 2009 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 2.55 | 5,000 | 12,750 | 15,000 | |
Feb 23 2009 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 2.49 | 15,000 | 37,350 | 749,609 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | A | 2.55 | 7,000 | 17,850 | 21,000 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 2.55 | 7,000 | 17,850 | 21,000 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 2.55 | 5,000 | 12,750 | 306,843 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 2.55 | 5,000 | 12,750 | 744,608 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | A | 2.49 | 15,000 | 37,350 | 452,766 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | A | 2.49 | 15,000 | 37,350 | 115,000 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | V.P. of Regulatory ... | Option Exercise | A | 2.49 | 15,000 | 37,350 | 160,922 | |
Feb 18 2009 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 2.49 | 15,000 | 37,350 | 65,000 | |
Jan 05 2009 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.69 | 1,417 | 2,395 | 3,086,071 | 3.1 M to 3.1 M (+0.05 %) |
Dec 29 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 1.60 | 1,000 | 1,600 | 261,182 | 260.2 K to 261.2 K (+0.38 %) |
Dec 23 2008 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.50 | 2,003 | 3,005 | 1,179,134 | 1.2 M to 1.2 M (+0.17 %) |
Dec 23 2008 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.65 | 1,000 | 1,650 | 1,177,131 | 1.2 M to 1.2 M (+0.09 %) |
Dec 23 2008 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.99 | 1,997 | 3,974 | 1,176,131 | 1.2 M to 1.2 M (+0.17 %) |
Dec 22 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 2.24 | 100 | 224 | 10,593 | 10.5 K to 10.6 K (+0.95 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.25 | 70 | 158 | 260,182 | 260.1 K to 260.2 K (+0.03 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.22 | 80 | 177 | 260,112 | 260 K to 260.1 K (+0.03 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.22 | 50 | 111 | 260,032 | 260 K to 260 K (+0.02 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.20 | 100 | 220 | 259,982 | 259.9 K to 260 K (+0.04 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.11 | 100 | 211 | 259,882 | 259.8 K to 259.9 K (+0.04 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.02 | 100 | 202 | 259,782 | 259.7 K to 259.8 K (+0.04 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 1.92 | 500 | 960 | 259,682 | 259.2 K to 259.7 K (+0.19 %) |
Dec 19 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 1.92 | 500 | 958 | 259,182 | 258.7 K to 259.2 K (+0.19 %) |
Dec 18 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.80 | 2,500 | 4,500 | 3,084,654 | 3.1 M to 3.1 M (+0.08 %) |
Dec 09 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.05 | 2,500 | 5,125 | 3,082,154 | 3.1 M to 3.1 M (+0.08 %) |
Nov 26 2008 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Buy | P | 1.85 | 2,500 | 4,625 | 9,846 | 7.3 K to 9.8 K (+34.03 %) |
Nov 26 2008 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Buy | P | 1.85 | 1,000 | 1,850 | 7,346 | 6.3 K to 7.3 K (+15.76 %) |
Nov 24 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.22 | 700 | 1,554 | 258,682 | 258 K to 258.7 K (+0.27 %) |
Nov 24 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.20 | 300 | 660 | 257,982 | 257.7 K to 258 K (+0.12 %) |
Nov 24 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 1.87 | 1,900 | 3,553 | 257,682 | 255.8 K to 257.7 K (+0.74 %) |
Nov 24 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 1.86 | 100 | 186 | 255,782 | 255.7 K to 255.8 K (+0.04 %) |
Nov 24 2008 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.19 | 3,900 | 8,543 | 63,876 | 60 K to 63.9 K (+6.50 %) |
Nov 24 2008 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.25 | 1,000 | 2,250 | 59,976 | 59 K to 60 K (+1.70 %) |
Nov 24 2008 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.32 | 200 | 463 | 58,976 | 58.8 K to 59 K (+0.34 %) |
Nov 13 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.41 | 300 | 723 | 255,682 | 255.4 K to 255.7 K (+0.12 %) |
Nov 13 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.38 | 200 | 476 | 255,382 | 255.2 K to 255.4 K (+0.08 %) |
Oct 31 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.50 | 700 | 1,750 | 255,182 | 254.5 K to 255.2 K (+0.28 %) |
Oct 31 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.49 | 300 | 747 | 254,482 | 254.2 K to 254.5 K (+0.12 %) |
Oct 31 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.75 | 4 | 11 | 254,182 | 254.2 K to 254.2 K (0.00 %) |
Oct 31 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.74 | 396 | 1,085 | 254,178 | 253.8 K to 254.2 K (+0.16 %) |
Oct 31 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.53 | 100 | 253 | 253,782 | 253.7 K to 253.8 K (+0.04 %) |
Oct 30 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 3.03 | 100 | 303 | 10,493 | 10.4 K to 10.5 K (+0.96 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.70 | 100 | 270 | 253,682 | 253.6 K to 253.7 K (+0.04 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.68 | 200 | 537 | 253,582 | 253.4 K to 253.6 K (+0.08 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.61 | 100 | 261 | 253,382 | 253.3 K to 253.4 K (+0.04 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.60 | 100 | 260 | 253,282 | 253.2 K to 253.3 K (+0.04 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.72 | 200 | 544 | 253,182 | 253 K to 253.2 K (+0.08 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.69 | 200 | 538 | 252,982 | 252.8 K to 253 K (+0.08 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.68 | 100 | 268 | 252,782 | 252.7 K to 252.8 K (+0.04 %) |
Oct 27 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.68 | 500 | 1,341 | 252,682 | 252.2 K to 252.7 K (+0.20 %) |
Oct 22 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.69 | 500 | 1,345 | 252,182 | 251.7 K to 252.2 K (+0.20 %) |
Oct 21 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.64 | 500 | 1,320 | 251,682 | 251.2 K to 251.7 K (+0.20 %) |
Oct 21 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.49 | 500 | 1,245 | 251,182 | 250.7 K to 251.2 K (+0.20 %) |
Oct 14 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.52 | 1,000 | 2,520 | 250,682 | 249.7 K to 250.7 K (+0.40 %) |
Oct 14 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.35 | 100 | 235 | 249,682 | 249.6 K to 249.7 K (+0.04 %) |
Oct 14 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.27 | 1,000 | 2,270 | 249,582 | 248.6 K to 249.6 K (+0.40 %) |
Oct 14 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.73 | 500 | 1,365 | 248,582 | 248.1 K to 248.6 K (+0.20 %) |
Oct 14 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.80 | 500 | 1,400 | 248,082 | 247.6 K to 248.1 K (+0.20 %) |
Oct 01 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.89 | 100 | 289 | 247,582 | 247.5 K to 247.6 K (+0.04 %) |
Oct 01 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.80 | 300 | 840 | 247,482 | 247.2 K to 247.5 K (+0.12 %) |
Oct 01 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.80 | 1,000 | 2,800 | 247,182 | 246.2 K to 247.2 K (+0.41 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.95 | 1,000 | 2,950 | 246,182 | 245.2 K to 246.2 K (+0.41 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.90 | 1,000 | 2,900 | 245,182 | 244.2 K to 245.2 K (+0.41 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.80 | 1,000 | 2,800 | 244,182 | 243.2 K to 244.2 K (+0.41 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 2.65 | 300 | 795 | 243,182 | 242.9 K to 243.2 K (+0.12 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 2.95 | 100 | 295 | 10,393 | 10.3 K to 10.4 K (+0.97 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 2.90 | 300 | 870 | 10,293 | 10 K to 10.3 K (+3.00 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.39 | 4,300 | 10,282 | 3,079,654 | 3.1 M to 3.1 M (+0.14 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.38 | 700 | 1,666 | 3,075,354 | 3.1 M to 3.1 M (+0.02 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.39 | 1,000 | 2,390 | 3,074,654 | 3.1 M to 3.1 M (+0.03 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.38 | 300 | 715 | 3,073,654 | 3.1 M to 3.1 M (+0.01 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.35 | 5,000 | 11,750 | 3,073,354 | 3.1 M to 3.1 M (+0.16 %) |
Sep 26 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.35 | 600 | 1,411 | 3,068,354 | 3.1 M to 3.1 M (+0.02 %) |
Sep 23 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.50 | 400 | 1,000 | 3,067,754 | 3.1 M to 3.1 M (+0.01 %) |
Sep 18 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 2.55 | 1,700 | 4,335 | 9,993 | 8.3 K to 10 K (+20.50 %) |
Sep 18 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 2.55 | 500 | 1,274 | 8,293 | 7.8 K to 8.3 K (+6.42 %) |
Sep 18 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 2.50 | 800 | 2,000 | 7,793 | 7 K to 7.8 K (+11.44 %) |
Sep 18 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.55 | 1,801 | 4,593 | 3,067,354 | 3.1 M to 3.1 M (+0.06 %) |
Sep 18 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.50 | 200 | 500 | 3,065,553 | 3.1 M to 3.1 M (+0.01 %) |
Jul 09 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | Chairman, President ... | Payment of Exercise | F | 3.38 | 415 | 1,403 | 3,065,353 | 3.1 M to 3.1 M (-0.01 %) |
Apr 28 2008 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Grant | A | 3.01 | 1,794 | 5,400 | 74,754 | 73 K to 74.8 K (+2.46 %) |
Jun 06 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 3.58 | 4,900 | 17,542 | 242,882 | 238 K to 242.9 K (+2.06 %) |
Jun 06 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 3.53 | 100 | 353 | 237,982 | 237.9 K to 238 K (+0.04 %) |
May 22 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 3.50 | 10,000 | 35,000 | 237,882 | 227.9 K to 237.9 K (+4.39 %) |
May 22 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 3.66 | 3,000 | 10,980 | 227,882 | 224.9 K to 227.9 K (+1.33 %) |
May 22 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 3.67 | 1,000 | 3,670 | 224,882 | 223.9 K to 224.9 K (+0.45 %) |
Apr 28 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Payment of Exercise | F | 3.46 | 513 | 1,775 | 3,065,255 | 3.1 M to 3.1 M (-0.02 %) |
Apr 28 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Grant | A | 3.01 | 3,140 | 9,451 | 3,065,768 | 3.1 M to 3.1 M (+0.10 %) |
Apr 28 2008 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Grant | A | 3.01 | 1,993 | 5,999 | 6,993 | 5 K to 7 K (+39.86 %) |
Apr 28 2008 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | V.P. of Regulatory ... | Grant | A | 3.01 | 1,794 | 5,400 | 1,794 | 0 to 1.8 K |
Apr 28 2008 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Grant | A | 3.01 | 1,346 | 4,051 | 16,346 | 15 K to 16.3 K (+8.97 %) |
Apr 28 2008 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 3.15 | 7,000 | 22,050 | 14,000 | |
Apr 22 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 3.15 | 5,000 | 15,750 | 10,000 | |
Mar 26 2008 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | A | 3.15 | 7,000 | 22,050 | 14,000 | |
Mar 26 2008 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 3.15 | 5,000 | 15,750 | 739,608 | |
Mar 26 2008 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 3.15 | 5,000 | 15,750 | 301,843 | |
Feb 11 2008 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Buy | P | 3.45 | 14,200 | 48,990 | 1,174,134 | 1.2 M to 1.2 M (+1.22 %) |
Feb 05 2008 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 3.35 | 5,000 | 16,750 | 223,882 | 218.9 K to 223.9 K (+2.28 %) |
Feb 01 2008 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Buy | P | 3.05 | 10,800 | 32,940 | 1,164,934 | 1.2 M to 1.2 M (+0.94 %) |
Jan 28 2008 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | Chairman, President ... | Buy | P | 3.05 | 25,100 | 76,555 | 3,099,307 | 3.1 M to 3.1 M (+0.82 %) |
Jan 28 2008 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.05 | 5,000 | 15,250 | 58,776 | 53.8 K to 58.8 K (+9.30 %) |
Nov 08 2007 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.00 | 4,924 | 14,772 | 48,776 | 43.9 K to 48.8 K (+11.23 %) |
Nov 20 2007 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.50 | 5,000 | 12,500 | 53,776 | 48.8 K to 53.8 K (+10.25 %) |
Sep 20 2007 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 3.94 | 5,000 | 19,700 | 305,000 | 300 K to 305 K (+1.67 %) |
Aug 30 2007 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.75 | 76 | 209 | 43,852 | 43.8 K to 43.9 K (+0.17 %) |
Aug 16 2007 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 3.00 | 5,000 | 15,000 | 5,000 | 0 to 5 K |
Jun 11 2007 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 4.00 | 3,334 | 13,336 | 10,000 | |
Jun 11 2007 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 4.00 | 3,333 | 13,332 | 6,666 | |
Jun 11 2007 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 4.00 | 3,333 | 13,332 | 3,333 | |
Apr 03 2007 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 3.69 | 5,000 | 18,450 | 295,000 | 290 K to 295 K (+1.72 %) |
Apr 03 2007 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 4.02 | 5,000 | 20,100 | 5,000 | 0 to 5 K |
Apr 03 2007 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Grant | A | 0.00 | 10,944 | 0 | 43,776 | 32.8 K to 43.8 K (+33.33 %) |
Mar 28 2007 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | A | 3.99 | 7,000 | 27,930 | 7,000 | |
Mar 29 2007 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 3.99 | 7,000 | 27,930 | 7,000 | |
Mar 28 2007 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 3.99 | 5,000 | 19,950 | 734,608 | |
Mar 26 2007 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 3.99 | 5,000 | 19,950 | 5,000 | |
Mar 26 2007 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 3.99 | 5,000 | 19,950 | 296,843 | |
Mar 15 2007 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 4.75 | 5,454 | 25,907 | 290,000 | 284.5 K to 290 K (+1.92 %) |